Petitions  Mr. Speaker, I am pleased to present this petition regarding CCSVI. The Conservative-dominated Senate committee is refusing to hear from those who have MS. Can anyone imagine a committee silencing a cancer patient, a heart patient or someone living in poverty? Why then are MS

Health committee  CCSVI is a medical procedure. My group in my branch is responsible for approving different products. If a product was to be used and manufacturers wanted to come forward and advertise their product for use in a procedure such as CCSVI, they would have to come through us. To date

Health committee  Well, if we look at Tysabri, we fast-tracked a drug knowing that it caused a fatal brain infection. I see a real dichotomy between the way CCSVI has been treated and the way Tysabri has been treated. I have spoken to the researcher who created the molecule. If we go back

Petitions  Mr. Speaker, I am pleased to present this petition regarding CCSVI. The Conservative dominated Senate committee is refusing to hear from those who have MS. Can anyone imagine a committee silencing a cancer patient, a heart patient or someone living in poverty? Why, then, are MS

Business of Supply   hunger”. In addition to serving my riding, I have the privilege of serving thousands of Canadians living with devastating multiple sclerosis, who bravely fight their disease each day and fight for clinical trials for CCSVI, as well as all those living with a brain disease, disorder

Petitions  Mr. Speaker, I am pleased to present this petition regarding CCSVI. Today marks 1 year, 87 days since the government promised clinical trials, and still there is no action. In this time we will potentially have lost another 480 people to devastating multiple sclerosis and those

Petitions  Mr. Speaker, I am pleased to present this petition regarding CCSVI. Today marks one year and eighty-two days since the government promised clinical trials on CCSVI. There is still no action and in this time we have potentially lost more than 450 people to devastating multiple

Questions Passed as Orders for Returns   and their practice of medicine guidelines, (ii) and if off-label use falls under provincial jurisdiction, why did the federal government intervene regarding the new procedure for chronic cerebrospinal venous insufficiency (CCSVI); (c) what are the regulatory requirements for the special access

Petitions  Mr. Speaker, the second petition is regarding CCSVI. The petitioners call for the Minister of Health to consult experts actively engaged in the diagnosis and treatment of CCSVI to undertake a phase III clinical trial on an urgent basis at multiple centres across Canada

Multiple Sclerosis  Mr. Speaker, today, Macleans's magazine published the article, “The Silent Treatment”, an exposé of the government's mishandling of CCSVI. It details explosive conflicts of interest, politics over science, and the Canadian Institutes of Health Research admitting, “We had

Multiple Sclerosis   in MS research, and we are supporting the development of an MS monitoring system that will provide patients and health care providers with better understanding of the disease and its treatments. It is critical that we complete clinical trials for CCSVI to assess the safety

Petitions  Mr. Speaker, I am pleased to present this petition on CCSVI. There is real concern among the community that, while the government fast-tracked a drug which was known to cause a fatal brain infection and has now infected 232 people and killed 49 people and another drug which

Petitions  Mr. Speaker, this petition is regarding CCSVI. Yesterday marked the two year anniversary since I first asked for an emergency debate on CCSVI in the House. In two years, 800 Canadians died of multiple sclerosis. It is also two years since the member for St. Paul's and myself

Questions on the Order Paper  With respect to clinical trials for chronic cerebrospinal venous insufficiency (CCSVI): (a) what was the deadline for receiving applications for clinical trials for CCSVI and has the application process closed; (b) how many applications were received, and, for each application

Questions on the Order Paper  Mr. Speaker, on April 18, 2012, the Minister of Health announced that a team of researchers has been selected to undertake an interventional phase I/II clinical trial for chronic cerebrospinal venous insufficiency, CCSVI, in persons with multiple sclerosis. The objective